Stem cells-derived islet transplantation toward clinical translation: Divergent strategies and convergent objectives
World Journal of Diabetes · 15.07.2026 · 17 (7)
DOI: 10.4239/wjd.119760 ↗Kurz gefasst
Fachartikel in der Zeitschrift World Journal of Diabetes, online erschienen am 15.07.2026. Verfasst von Duo-Wen He und 9 weiteren Autor:innen. Die Arbeit nennt 81 Literaturangaben.
Abstract (Originalsprache)
Diabetes mellitus, a chronic metabolic disease with high global prevalence, is in urgent need of breakthrough therapies due to its high risk of complications and limitations of current treatments. Stem cells-derived differentiated islet transplantation represents a promising therapeutic strategy for diabetes mellitus by enabling the regeneration of functional islet cells and the restoration of endogenous insulin secretion. This review provided a comprehensive overview of stem cells-based islet differentiation and transplantation technologies, including the classification and functional roles of different stem cell types. It systematically compared the current research status and strategic differences among leading centers and platforms. In addition, the major translational challenges were critically analyzed, with particular emphasis on immunological barriers, long term graft function, and clinical scalability, alongside insights drawn from the authors’ clinical experience. Furthermore, this review explored future research directions that are expected to drive clinical translation, including the application of gene editing technologies, the optimization of immunomodulatory strategies, and advances in pancreatic islet cryopreservation. Despite rapid progress in the field, a systematic comparison of stem cells-derived islet strategies, particularly with respect to immune compatibility, manufacturability, and individualized therapeutic potential, remains limited. This review addressed this gap by presenting an integrated analysis of current approaches, contextualized by clinical experience, and by proposing future multidisciplinary strategies that combine gene-editing, localized immunomodulation, and improved cryopreservation techniques to advance stem cell-derived islet transplantation toward broader clinical application.
Zitieren
APA
He, D., Zhang, F., Zhang, H., Xiao, S., Bi, X., Wang, Y., Wang, R., Lu, Y., Yin, H., & Li, T. (2026). Stem cells-derived islet transplantation toward clinical translation: Divergent strategies and convergent objectives. World Journal of Diabetes, 17(7). https://doi.org/10.4239/wjd.119760
Vancouver
He D, Zhang F, Zhang H, Xiao S, Bi X, Wang Y, et al. Stem cells-derived islet transplantation toward clinical translation: Divergent strategies and convergent objectives. World Journal of Diabetes. 2026;17(7). doi:10.4239/wjd.119760
BibTeX
@article{He2026,
author = {He, Duo-Wen and Zhang, Fu-Rong and Zhang, Hong-Xi and Xiao, Shu-Yan and Bi, Xiao-Yan and Wang, Yi-Man and Wang, Ru-Lan and Lu, Yi-Xian and Yin, Hao and Li, Tuo},
title = {Stem cells-derived islet transplantation toward clinical translation: Divergent strategies and convergent objectives},
journal = {World Journal of Diabetes},
year = {2026},
volume = {17},
number = {7},
doi = {10.4239/wjd.119760}
}
EUVIMED